Maison Sativa – Expert du CBD premium en France

CBD, or cannabidiol, is a natural compound extracted from industrial hemp (Cannabis sativa L.). It is one of the cannabinoids, which are active substances found in the cannabis plant. Unlike THC, CBD does not cause psychotropic effects and is recognized for its relaxing properties. It is used in various products such as oils, capsules, creams, and infusions.​

No, cannabis is a plant, whereas CBD is a molecule produced by it.

Cannabis synthesizes numerous active molecules called cannabinoids, among which are CBD (cannabidiol) and THC (tetrahydrocannabinol). These two substances have very different effects: THC is psychotropic—it causes euphoric effects and altered perception—whereas CBD has no psychotropic effects. It is known for its relaxing, anti-inflammatory, and pain-relieving properties.

In France, when we speak of CBD, we are often referring in a simplified way to products derived from hemp, a variety of cannabis specially cultivated for its low THC content (less than 0.3%). CBD is therefore not strictly speaking cannabis, but a molecule naturally present in this plant, used for its benefits without psychotropic side effects.

Hemp is a variety of the cannabis plant grown for its fibers, seeds, and active compounds such as CBD. CBD is one of the many cannabinoids found in hemp, used for its beneficial effects on well-being without the psychoactive effects of THC.

Yes, CBD is legal in France if it is extracted from hemp varieties authorized by the European catalogue and contains less than 0.3% THC. It can be marketed in the form of oils, capsules, creams, raw flowers or concentrates, provided that the regulations in force are respected.

The consumption of CBD flowers and resins is authorized in France if they comply with the legal THC limit. However, it is recommended to favor consumption methods without combustion, such as infusions or vaporizers, to preserve health.

It is possible to travel with CBD within the European Union, provided that the product complies with local legislation, particularly regarding the THC level. It is advisable to keep the product in its original packaging and to check the laws of the destination country before departure.

Studies suggest that CBD may help reduce anxiety symptoms by interacting with the body's endocannabinoid system. It promotes a sense of calm and relaxation without causing major side effects.​

CBD is often used to improve sleep quality. By reducing stress and anxiety, it can promote falling asleep and increase sleep duration, thereby contributing to more restorative rest.​

When consumed appropriately, CBD can offer various health benefits, including the reduction of stress, anxiety, and chronic pain. It is important to choose quality products and consult a healthcare professional in case of doubt.​

CBD is generally well tolerated, but some users may experience side effects such as dry mouth, drowsiness, digestive issues, or a decreased appetite. These effects are usually mild and temporary.​

CBD is available in various forms: oils, capsules, creams, infusions, e-liquids, etc. Each form offers a method of consumption adapted to everyone's needs and preferences.

To preserve the quality of CBD, it is recommended to store it in an amber glass container, away from light, heat, and humidity. Maison Sativa's amber glass jars are ideal for this storage.​

In France, CBD is not classified as a medication, but rather as a food supplement or a wellness product. This means that it cannot under any circumstances be presented as a treatment to cure or prevent a disease, unless the product has obtained a marketing authorization (MA) issued by health authorities. Currently, only one CBD-based medication (Epidyolex) is authorized for rare forms of epilepsy. For any other use, brands must refrain from making therapeutic claims. In the event of a medical condition, it is always recommended to consult a healthcare professional before using CBD.

The consumption of CBD during pregnancy or breastfeeding is strongly advised against. Scientific data on the effects of cannabidiol on the fetus or infant are still insufficient to guarantee its safety at these sensitive stages of life. Even though CBD is a natural and non-psychoactive substance, it acts on the endocannabinoid system, which plays a crucial role in neurological development. As a precautionary principle, it is best to avoid taking any CBD during this period, except by exceptional medical prescription. Discuss it with your doctor before any consumption.

In France, the purchase and consumption of CBD-based products are strictly reserved for adults, meaning individuals aged 18 and over. This limit is in place to protect minors, as no studies have yet confirmed the safety of cannabidiol for a developing body. However, in certain well-regulated medical cases, a healthcare professional may consider occasional use in adolescents. Outside of these exceptional situations, caution remains the rule.

Yes, there are now CBD products specially formulated for animals, particularly for dogs and cats. These solutions can be used to relieve anxiety, stress, or even joint pain in aging animals. However, be careful: it is essential to use products designed for animals, free from flavorings, terpenes, or THC, which can be toxic to them. Always consult your veterinarian before administering CBD to your four-legged companion to adjust the dosage and avoid any drug interactions.